FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
ResMed Inc. Stock AnalysisComprehensive stock analysis for ResMed Inc. (RMD.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisRMD.AX
RMD.AX
ResMed Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RMD.AX
Home🔹Stocks🔹ResMed Inc.

ResMed Inc.

🇦🇺RMD.AX•ASX

ResMed Inc.

🇦🇺RMD.AX•ASX
Sentiment

Your view on RMD.AX

Sentiment
Your view
RMD.AX
ResMed Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
RMD.AX
Company Overview

Overview

What the company does, where it operates, and who runs it.

About ResMed Inc.

Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Michael J. Farrell
Headquarters
9001 Spectrum Center Boulevard, San Diego, CA, US
Industry
Medical - Instruments & Supplies
Sector
Healthcare
CEO
Michael J. Farrell
Headquarters
9001 Spectrum Center Boulevard, San Diego, CA, US
Description

ResMed Inc. designs, manufactures, and markets innovative medical devices and sophisticated cloud-based software platforms for the global healthcare industry, operating through its Sleep and Respiratory Care, and Software as a Service divisions.

Within its Sleep and Respiratory Care segment, the company offers a comprehensive range of solutions for various respiratory disorders. These include cutting-edge ventilation devices, diagnostic tools, diverse mask systems suitable for hospital and home environments, headgear, accessories, and specialized dental devices.

These hardware offerings are integrated with cloud-based informatics solutions designed to optimize patient management and improve clinical results.

Prominent software applications in this area feature AirView, a cloud platform for remote patient monitoring and device setting modifications; myAir, a personalized therapy management tool for sleep apnea sufferers, providing education, support, and troubleshooting to enhance engagement and adherence; and U-Sleep, a compliance monitoring system that streamlines sleep programs for home medical equipment (HME) providers.

The company also offers connectivity modules and Propeller solutions. The Software as a Service division specializes in out-of-hospital care solutions. Brightree provides business management software and services to providers in the home medical equipment, pharmacy, home infusion, orthotics, and prosthetics sectors.

MatrixCare delivers care management and ancillary solutions to senior living communities, skilled nursing facilities, life plan communities, home health, home care, and hospice organizations, including related accountable care organizations.

Furthermore, HEALTHCAREfirst supplies electronic health record (EHR) systems, software, billing and coding services, and analytics tailored for home health and hospice agencies.

ResMed distributes its extensive product line to sleep clinics, home healthcare dealers, and hospitals in approximately 140 countries, utilizing both a direct sales force and a network of distributors. The company was founded in 1989 and is based in San Diego, California.

FRC Research

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for ResMed Inc., and the rating behind it. RMD.AX last traded at AUD 28.87, 21.0× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for ResMed Inc.. Starting points for ResMed Inc.: P/E 21.0, EPS AUD 10.53, beta 0.77 — an Medical - Instruments & Supplies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for ResMed Inc.. ResMed Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for ResMed Inc.. Trailing twelve-month EPS for ResMed Inc. stands at AUD 10.53. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for ResMed Inc.. ResMed Inc. has reported as a listed company since 1999. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

ResMed Inc. valued side by side against its closest peers. ResMed Inc. is measured against Medical - Instruments & Supplies peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold ResMed Inc., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by ResMed Inc. executives and directors. Shares of ResMed Inc. have traded between AUD 25.50 and AUD 45.25 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming ResMed Inc.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming ResMed Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for ResMed Inc.. Coverage tracks ResMed Inc. within Medical - Instruments & Supplies (Healthcare). Press releases and market coverage, newest first.

Peer companies

  • AHC.AX — Austco Healthcare Limited
  • ANN.AX — Ansell Limited
  • CSL.AX — CSL Limited
  • EBO.AX — Ebos Group Limited
  • FPH.AX — Fisher & Paykel Healthcare Corporation Limited
  • NAN.AX — Nanosonics Limited
  • OSX.AX — Osteopore Limited

More Medical - Instruments & Supplies companies

  • SMTI — Sanara MedTech Inc.
  • SOAGY — Sartorius AG
  • SOLV — Solventum Corporation
  • SRTOY — Sartorius Stedim Biotech S.A.
  • SSSGY — Sartorius AG
  • STAA — STAAR Surgical Company
  • STSS — Sharps Technology, Inc.
  • STVN — Stevanato Group S.p.A.
  • STXS — Stereotaxis, Inc.
  • SUVPF — Sartorius AG
  • SVSO — SheerVision, Inc.
  • TCGGY — Tecan Group AG

ETFs holding ResMed Inc.

  • FAIR.AX — BetaShares - Australian Sustainability Leaders ETF (3.49%)
  • FHH.TO — First Trust AlphaDEX U.S. Health Care Sector Index ETF (1.87%)
  • EX20.AX — BetaShares - Australian Ex-20 Portfolio Diversifier ETF (1.76%)
  • GEAR.AX — BetaShares - Geared Australian Equities Complex ETF (1.35%)
  • SFY.AX — State Street SPDR S&P/ASX 50 ETF (0.81%)
  • TDOC.TO — TD Global Healthcare Leaders Index ETF (0.77%)
  • STW.AX — State Street SPDR S&P/ASX 200 ETF (0.64%)
  • A200.AX — BetaShares - Australia 200 ETF (0.64%)

News

Latest Market News